Scarica l'app Stockscreener
0.0222
0.00%
0.00
Dopo l'orario di chiusura:
.02
-0.0022
-9.91%
Precedente Chiudi:
$0.0222
Aprire:
$0.0454
Volume 24 ore:
29,701
Relative Volume:
3.98
Capitalizzazione di mercato:
$N/A
Reddito:
$389.80K
Utile/perdita netta:
$-5.33M
Rapporto P/E:
-0.00921
EPS:
-2.4117
Flusso di cassa netto:
$-4.78M
1 W Prestazione:
-84.38%
1M Prestazione:
-86.94%
6M Prestazione:
-96.30%
1 anno Prestazione:
-79.60%
Intervallo 1D:
$0.0222
$0.0454
Intervallo di 1 settimana:
$0.0222
$0.121
Portata 52W:
$0.0222
$0.80
Lipella Pharmaceuticals Inc Stock (LIPO) Company Profile
Nome
Lipella Pharmaceuticals Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare LIPO vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LIPO
Lipella Pharmaceuticals Inc
|
0.0222 | 0 | 389.80K | -5.33M | -4.78M | -2.4117 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Lipella Pharmaceuticals Inc Borsa (LIPO) Ultime notizie
Lipella Pharmaceuticals files for bankruptcy protection four years after going public - WPXI
Stock List: Research Stocks from Around the World - GuruFocus
Pittsburgh biotech company Lipella Pharmaceuticals files for bankruptcy protection - TribLIVE.com
Future Perspectives: Key Trends Shaping the Lichen Planus Market Until 2030 - openPR.com
Sell Signal: Is Lipella Pharmaceuticals Inc forming a breakout pattern2026 Bull vs Bear & Real-Time Price Movement Reports - baoquankhu1.vn
Lipella Pharmaceuticals Begins Chapter 11 Bankruptcy Restructuring Process - TipRanks
Biotech Company Files for Chapter 11 Bankruptcy, Plans Asset Sale - WhatNow
Fierce Biotech Layoff Tracker 2026: Lipella, IO shutter; Takeda plots 634 US job cuts - fiercebiotech.com
Lipella Pharmaceuticals Files for Chapter 11 Bankruptcy - National Today
Entry Recap: Will ELAB benefit from rising consumer demandAnalyst Upgrade & Entry Point Confirmation Alerts - baoquankhu1.vn
Tenaris Files its 2025 Annual Report and its Annual Report on Form 20-F - The Manila Times
US Senators send letter to SEC, requesting explanation for former enforcement chief's brief tenure and reversal of decisions on crypto cases - Bitget
Legal risks combined with AI's high costs cause Meta's market value to evaporate by $280 billions, raising concerns about tobacco industry-style risks - Bitget
Lipella Pharmaceuticals Inc plans to file customary "first day" relief motions with the court. - Bitget
Tims China Announces Q4 and Full Year 2025 Results Conference Call - The Manila Times
Lipella Pharmaceuticals Inc. Files Voluntary Petitions for Relief Under Chapter 11 - The Manila Times
Dropship China Pro Expands US Fulfillment Warehouse Operations to Meet Growing Demand for Faster E-commerce Delivery - The Manila Times
Lipella Pharmaceuticals Inc. Files Voluntary Petitions For Relief Under Chapter 11 - TradingView
Lipella Pharmaceuticals Inc.: Fundamental Analysis and Financial Ratings | | US53630L2097 - marketscreener.com
Patterns Watch: Whats the beta of Lipella Pharmaceuticals Inc stockRecession Risk & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Decliners Report: Can Lipella Pharmaceuticals Inc maintain its current growth rate2026 Intraday Action & Trade Opportunity Analysis Reports - baoquankhu1.vn
Price Action: Can Lipella Pharmaceuticals Inc grow without external fundingWeekly Trade Report & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Chipmakers Recap: What is the next catalyst for Lipella Pharmaceuticals IncJuly 2025 Opening Moves & Target Return Focused Stock Picks - baoquankhu1.vn
Dip Buying: How does Lipella Pharmaceuticals Inc score in quality rankingsPortfolio Update Summary & Stock Timing and Entry Methods - baoquankhu1.vn
LIPO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Short Covering: Is Lipella Pharmaceuticals Inc a strong candidate for buy and holdJuly 2025 Selloffs & Weekly Market Pulse Updates - baoquankhu1.vn
Will Lipella Pharmaceuticals Inc. stock hit new highs in YEARJuly 2025 Gainers & Stock Timing and Entry Methods - mfd.ru
Will Lipella Pharmaceuticals Inc. stock pay special dividendsJuly 2025 Snapshot & Weekly High Return Stock Forecasts - mfd.ru
Investment Review: What is the next catalyst for Lipella Pharmaceuticals Inc2025 Analyst Calls & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Published on: 2026-02-14 23:53:09 - mfd.ru
Pullback Watch: Is ATIIU subject to activist investor interestWeekly Trade Report & AI Forecast Swing Trade Picks - baoquankhu1.vn
Interstitial Cystitis Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | UCB Pharma, Lipella Pharma, Allergan, PureTech Health, Imbrium - Barchart.com
Is Lipella Pharmaceuticals Inc. stock good for income investorsCEO Change & Free Expert Verified Stock Movement Alerts - mfd.ru
Lipella Pharmaceuticals (NASDAQ:LIPO) Trading Up 31.8% – Should You Buy? - Defense World
Valuation Update: What is the next catalyst for Lipella Pharmaceuticals IncJuly 2025 Catalysts & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Bull Run: Can Lipella Pharmaceuticals Inc be recession proofJuly 2025 Summary & Daily Chart Pattern Signals - baoquankhu1.vn
Lipella Pharmaceuticals Announces Resignation of Board Member - TipRanks
What’s the beta of Lipella Pharmaceuticals Inc. stockJuly 2025 Opening Moves & Free Daily Entry Point Trade Alerts - mfd.ru
Is Lipella Pharmaceuticals Inc. subject to activist investor interestJuly 2025 Snapshot & Weekly High Return Stock Forecasts - mfd.ru
Fed Meeting: Is TBBKs ROE strong enoughQuarterly Performance Summary & Community Consensus Stock Picks - baoquankhu1.vn
EV Market: How volatile is Lipella Pharmaceuticals Inc stock2025 Earnings Surprises & Weekly High Return Stock Opportunities - baoquankhu1.vn
Momentum Shift: Is Lipella Pharmaceuticals Inc. a strong candidate for buy and holdTrade Risk Assessment & Weekly Return Optimization Plans - baoquankhu1.vn
A | Can A19QHV expand into new marketsMarket Activity Recap & AI Driven Price Predictions - bollywoodhelpline.com
Buy Signal: Will Lipella Pharmaceuticals Inc stock maintain momentum in 2025July 2025 Big Picture & Growth Oriented Trading Recommendations - Bộ Nội Vụ
Graft Versus Host Disease Treatment Pipeline Shows Strong Momentum as 45+ Pharma Companies in the Race | DelveInsight - Barchart.com
Market Review: How Lipella Pharmaceuticals Inc stock reacts to bond yieldsTrade Ideas & Real-Time Buy Zone Alerts - Bộ Nội Vụ
How Lipella Pharmaceuticals Inc. stock reacts to bond yieldsWalking Comfort Picks & compare fit, width, and feel - ulpravda.ru
2026 world cup brazil semifinals key players transition play knockout prediction tactical reviewWeekly Gains Report & Safe Entry Point Alerts - Улправда
P 500 Buffer 12 stock beat growth indexesJuly 2025 WrapUp & AI Powered Market Entry Strategies - Улправда
Is Lipella Pharmaceuticals Inc. stock positioned for long term growthJuly 2025 WrapUp & Fast Gain Stock Trading Tips - Улправда
Is Lipella Pharmaceuticals Inc. stock a bargain at current levelsQuarterly Market Review & Comprehensive Market Scan Insights - ulpravda.ru
Lipella Pharmaceuticals Inc Azioni (LIPO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Capitalizzazione:
|
Volume (24 ore):